Immunic investor relations

WitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent … Witryna28 lip 2024 · Q1 2024 Athenex Inc. Earnings Conference Call. Monday, March 01, 2024 8:00 am EST. Q4 and Full Year 2024 Athenex, Inc. Earnings Conference Call. Monday, January 11, 2024 8:40 am EST. ATNX at 39th Annual J.P. Morgan Healthcare Conference. Wednesday, December 09, 2024 5:00 pm EST.

Immunic, Inc. to Participate in Investor Conferences in September

Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and CommunicationsDaniel Vitt - CEO and... fishlake national forest utah pando https://borensteinweb.com

Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript

WitrynaM.A. Business Management Student, Investor Relations and PR at Immunic Therapeutics Metropolregion München. 95 Follower:innen … Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. Rx Communications … WitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune … fish lake near duluth mn

Immunic, Inc. to Participate in Scientific and Investor ... - Insider

Category:Immunic, Inc. to Announce Financial Results for the Third Quarter …

Tags:Immunic investor relations

Immunic investor relations

Immunic, Inc. Announces $60.0 Million Oversubscribed Private …

Witryna4 paź 2024 · Members of Immunic's business development and investor relations teams will attend this conference in Leipzig, ... Head of Investor Relations and Communications +49 89 2080 477 09 Witryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of …

Immunic investor relations

Did you know?

Witryna8 mar 2024 · Archived Events. Date. Event Details. Mar 8, 2024 10:30 AM EST. 43rd Annual Cowen Health Care Conference. Listen to webcast. Feb 6, 2024 4:30 PM EST. Arrowhead Pharmaceuticals 2024 First Quarter Results. Listen to webcast. Witryna23 lut 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q4 2024 Earnings Conference Call February 23, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR & CommunicationsDaniel Vitt - CEO, President...

Witryna2 dni temu · Telenor ASA appointed Frank Maao as senior vice president for capital markets and investor relations, according to a statement. Maao comes from the … WitrynaSEC Filings. Select the filing type and date range you wish to view from the drop-down menus below. An annual report to security holders. Open An annual report to security holders. in HTML. Open An annual report to security holders. in DOC file. Open An annual report to security holders. in PDF file.

Witryna1 kwi 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical … Witryna10 lis 2024 · Members of Immunic's management and investor relations teams will attend this virtual conference. To schedule a meeting, please contact an Evercore representative. ... Head of Investor Relations ...

Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. …

Witryna24 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … fishlake national forest vacation packagesWitryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE … can chloroplasts form amyloplastsWitryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining … fish lake new yorkWitryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... can chlorox be used in poolWitrynaInvestor updates. Past IR events View all events. Investors. 2024 Credit Suisse Global Healthcare Conference. Read more. Investors. ... Investor relations team contacts. Genentech. Genentech has been delivering on the promise of biotechnology for over 35 years. Discover more. Contact. Locations. fishlake national forest weatherWitryna17 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Melody Carey +1 917 322 2571 [email protected]. US Media Contact KOGS Communication Edna Kaplan +1 781 639 1910 [email protected] fish lake near lake wenatcheefish lake near leavenworth